Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada
· Delayed Price · Currency is CAD 9.77
-0.10 (-1.01%)
Apr 28, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 80.56 | 33.1 | 19.34 | 18.26 | 16.51 | Upgrade
|
| Short-Term Investments | - | - | - | - | 7.12 | Upgrade
|
| Cash & Short-Term Investments | 80.56 | 33.1 | 19.34 | 18.26 | 23.63 | Upgrade
|
| Cash Growth | 143.39% | 71.14% | 5.91% | -22.70% | 19954.27% | Upgrade
|
| Other Receivables | 0.67 | 0.23 | 0.19 | 0.09 | 0.34 | Upgrade
|
| Receivables | 0.67 | 0.23 | 0.19 | 0.09 | 0.34 | Upgrade
|
| Prepaid Expenses | 3.86 | 1.11 | 0.27 | 0.24 | 0.21 | Upgrade
|
| Total Current Assets | 85.1 | 34.44 | 19.8 | 18.59 | 24.18 | Upgrade
|
| Property, Plant & Equipment | 0.99 | 0.42 | 0.46 | 0.53 | 0.47 | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.08 | 0.01 | 0 | 0.02 | Upgrade
|
| Total Assets | 86.15 | 34.94 | 20.27 | 19.12 | 24.67 | Upgrade
|
| Accrued Expenses | 5.51 | 3.01 | 3.87 | 2.91 | 1.67 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 10.4 | 0.08 | 0.08 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Current Income Taxes Payable | 0 | - | 0.04 | - | - | Upgrade
|
| Other Current Liabilities | 0.04 | 0.02 | 5.02 | 0.02 | 0 | Upgrade
|
| Total Current Liabilities | 5.63 | 3.1 | 19.37 | 3.06 | 1.79 | Upgrade
|
| Long-Term Debt | - | - | - | 8.8 | 7.66 | Upgrade
|
| Long-Term Leases | 0.08 | - | - | 0.05 | 0.11 | Upgrade
|
| Total Liabilities | 5.7 | 3.1 | 19.37 | 11.91 | 9.56 | Upgrade
|
| Common Stock | 195.41 | 116.36 | 92.91 | 71 | 61.36 | Upgrade
|
| Additional Paid-In Capital | 28.52 | 20.5 | 17.51 | 16.85 | - | Upgrade
|
| Retained Earnings | -169.58 | -131 | -105.5 | -77.28 | -58.68 | Upgrade
|
| Comprehensive Income & Other | -2.04 | -4.16 | -2.71 | -2.79 | 13.09 | Upgrade
|
| Total Common Equity | 52.3 | 1.7 | 2.22 | 7.79 | 15.77 | Upgrade
|
| Minority Interest | -1.6 | -1.57 | -1.32 | -0.58 | -0.66 | Upgrade
|
| Shareholders' Equity | 80.45 | 31.84 | 0.89 | 7.21 | 15.11 | Upgrade
|
| Total Liabilities & Equity | 86.15 | 34.94 | 20.27 | 19.12 | 24.67 | Upgrade
|
| Total Debt | 0.15 | 0.07 | 10.45 | 8.99 | 7.9 | Upgrade
|
| Net Cash (Debt) | 80.41 | 33.03 | 8.89 | 9.28 | 15.73 | Upgrade
|
| Net Cash Growth | 143.45% | 271.55% | -4.18% | -41.03% | - | Upgrade
|
| Net Cash Per Share | 2.01 | 0.97 | 0.37 | 0.48 | 1.27 | Upgrade
|
| Filing Date Shares Outstanding | 61.5 | 35.85 | 35.62 | 27.36 | 14.24 | Upgrade
|
| Total Common Shares Outstanding | 51.94 | 35.64 | 27.28 | 21.59 | 14.24 | Upgrade
|
| Working Capital | 79.47 | 31.33 | 0.43 | 15.53 | 22.39 | Upgrade
|
| Book Value Per Share | 1.01 | 0.05 | 0.08 | 0.36 | 1.11 | Upgrade
|
| Tangible Book Value | 52.3 | 1.7 | 2.22 | 7.79 | 15.77 | Upgrade
|
| Tangible Book Value Per Share | 1.01 | 0.05 | 0.08 | 0.36 | 1.11 | Upgrade
|
| Buildings | - | - | - | - | 0.07 | Upgrade
|
| Machinery | 1.35 | 0.7 | 0.68 | 0.61 | 0.1 | Upgrade
|
| Leasehold Improvements | 0.13 | 0.12 | 0.13 | 0.13 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.